Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Understanding the link between mitochondrial dysfunction and inflammation in bipolar disorder
FY 2015-16
Summary
Bipolar disorder (BD) is a debilitating and chronic mental illness. BD is characterized by fluctuations of mood between depressive, manic, and neutral states. BD has an estimated lifetime prevalence of about 2% in North America. BD is associated with increased medical burden and mortality; individuals with BD are ~20 times more likely to die by suicide compared to the general population. Dysfunction of mitochondria and inflammation in the brain are two of the most commonly observed alterations in studies of patients with BD. As such, it is possible that these alterations are fundamental features of BD. The goal of my research is to characterize the pathway connecting these two findings as a way to better understand this illness. We are currently focused on the protein Nlrp3 (full name: NOD-like receptor family, pyrin domain containing 3) as a possible link. Mitochondria are organelles responsible for producing energy in the cell and coordinate other cellular functions. When mitochondria are dysfunctional, particular signaling molecules are released. These signals cause Nlrp3 to associate with other proteins and form a complex termed the “Nlrp3 inflammasome,” which promotes inflammation. Chronic activation of the Nlrp3 inflammasome in the brain damages brain cells. Altered mood may be a product of damage to brain cells, as normal brain circuitry becomes altered.The study of this pathway will contribute to our fundamental understanding of this illness. The ultimate goal of our research is to develop medicines that inhibit the inappropriate activation of Nlrp3, thereby reducing inflammation. As inflammation damages brain cells and may ultimately produce the symptoms of BD, we believe that such medicines may reduce the severity of the disease.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
349893
Name
Pan Alexander Y
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding the link between mitochondrial dysfunction and inflammation in bipolar disorder
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bipolar Disorder; Complex I; Electron Transport Chain; Inflammation; Mitochondria; Mood Disorder; Nalp3; Nlrp3; Nod-Like Receptor Pyrin Domain-Containing 3; Psychiatry
Abstract
Bipolar disorder (BD) is a debilitating and chronic mental illness. BD is characterized by fluctuations of mood between depressive, manic, and neutral states. BD has an estimated lifetime prevalence of about 2% in North America. BD is associated with increased medical burden and mortality; individuals with BD are ~20 times more likely to die by suicide compared to the general population. Dysfunction of mitochondria and inflammation in the brain are two of the most commonly observed alterations in studies of patients with BD. As such, it is possible that these alterations are fundamental features of BD. The goal of my research is to characterize the pathway connecting these two findings as a way to better understand this illness. We are currently focused on the protein Nlrp3 (full name: NOD-like receptor family, pyrin domain containing 3) as a possible link. Mitochondria are organelles responsible for producing energy in the cell and coordinate other cellular functions. When mitochondria are dysfunctional, particular signaling molecules are released. These signals cause Nlrp3 to associate with other proteins and form a complex termed the “Nlrp3 inflammasome,” which promotes inflammation. Chronic activation of the Nlrp3 inflammasome in the brain damages brain cells. Altered mood may be a product of damage to brain cells, as normal brain circuitry becomes altered.The study of this pathway will contribute to our fundamental understanding of this illness. The ultimate goal of our research is to develop medicines that inhibit the inappropriate activation of Nlrp3, thereby reducing inflammation. As inflammation damages brain cells and may ultimately produce the symptoms of BD, we believe that such medicines may reduce the severity of the disease.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pan, Alexander Y
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~